Ledger.Open graph →
SEC Form D · filed January 24, 2022

ACELRX PHARMACEUTICALS INC

Offering
$6.0M
Sold
$5.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Hayward, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Richard P. Afable · Hayward, CADirectorBadri Dasu · Hayward, CAExecHoward Rosen · Hayward, CADirectorVincent Angotti · Hayward, CAExec · DirectorStephen Hoffman · Chicago, ILDirectorMark Edwards · Hayward, CADirectorMarina Bozilenko · Atlanta, GADirectorJill Broadfoot · San Diego, CADirectorAdrian Adams · Vancouver, British Columbia, CanadaDirectorRaffi Asadorian · Hayward, CAExecPamela Palmer · Hayward, CAExec · DirectorMichelle S. Riley · New York, NYDirectorMark Wan · Mountain View, CADirectorJames Moldane · CASTLE PINES, CODirectorMark Wan · Portola Valley, CADirectorBadri Dasu · Hayward, CAExecHoward Rosen · St. Paul, MNDirectorVincent Angotti · Hayward, CAExec · DirectorStephen Hoffman · Watertown, MADirectorMark Edwards · Edison, NJDirectorMarina Bozilenko · San Francisco, CADirectorJill Broadfoot · Hayward, CADirectorAdrian Adams · Vancouver, British Columbia, CanadaDirectorRaffi Asadorian · Hayward, CAExecPamela Palmer · Hayward, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗